CDXC 8K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________
FORM 8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR
15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): March 12, 2018
CHROMADEX CORPORATION
(Exact name of registrant as specified in its
charter)
|
Delaware
|
001-37752
|
26-2940963
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
10005 Muirlands Boulevard, Suite G, Irvine, California,
92618
(Address
of principal executive offices, including zip code)
(949) 419-0288
(Registrant's telephone number, including area
code)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[
]Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[
]Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[
]Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[
]Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the
registrant is an emerging growth company as defined in
Rule 405 of the Securities
Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act
of 1934 (§240.12b-2 of
this chapter).
Emerging growth
company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Item
7.01 Regulation FD
Disclosure.
On
March 12, 2018, ChromaDex Corporation released a corporate
presentation which it made available on its website and which it
will utilize in its presentation at the 30th Annual ROTH Capital
Partners Conference on March 12, 2018 at the Ritz-Carlton Hotel in
Dana Point, California.
The
information in this report (including Exhibit 99.1 hereto) is being
“furnished” and shall not be deemed “filed”
for the purposes of Section 18 of the Securities Exchange Act of
1934, as amended, is not subject to the liabilities of that section
and is not deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Securities Exchange Act
of 1934, as amended, except as shall be expressly set forth by
specific reference in such a filing.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit
|
|
Description
|
|
|
|
|
|
|
Investor
Presentation of ChromaDex Corporation
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
CHROMADEX CORPORATION
|
|
|
|
|
|
Dated: March 12,
2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Kevin
Farr
|
|
|
|
|
|
|
|
Name: Kevin
Farr
|
|
|
|
|
|
|
|
Chief Financial
Officer
|
